Skip to main content
Top
Published in: BMC Gastroenterology 1/2019

Open Access 01-12-2019 | Celiac Disease | Research article

The impact of diagnosis on health-related quality of life in people with coeliac disease: a UK population-based longitudinal perspective

Authors: Mara Violato, Alastair Gray

Published in: BMC Gastroenterology | Issue 1/2019

Login to get access

Abstract

Background

Before diagnosis, people with coeliac disease suffer reduced quality of life, which improves substantially after the disease has been diagnosed. Delayed diagnosis is common. The aim of this study was to assess changes over time in prevalence of coeliac disease symptoms/associated medical conditions, time to diagnosis, quality of life and its determinants before and after diagnosis in the United Kingdom.

Methods

A postal questionnaire was designed in 2015 and sent to 4000 individuals with diagnosed coeliac disease, requesting information on respondents’ socio-demographic and clinical characteristics, and their quality of life pre- and post-diagnosis using the EQ-5D instrument. Data were analysed and compared with results from a survey conducted in 2006 using descriptive analyses, univariate and multivariable regression methods.

Results

The survey response rate was 40%. Sixty-five percent of respondents reported at least 4 symptoms pre-diagnosis, a significant reduction by 13 percentage points (95% CI: -16.9, − 9.4; p-value: < 0.001) compared to 2006. Pre-diagnosis mean duration of symptoms was 12.8 years (SD: 15.3), a non-significant reduction of 0.6 years (95% CI: -2, 0.8; p-value: 0.426) compared to 2006. There was a significant improvement of 0.20 (95% CI: 0.18, 0.22; p-value: < 0.001) in quality of life from pre- (0.65) to post-diagnosis (0.85). Pre-diagnosis values were significantly higher by 0.09 (95% CI: 0.06, 0.12; p-value: < 0.001) than in 2006. Number of symptoms and low income were associated with decreased quality of life.

Conclusions

Undiagnosed coeliac disease is associated with a substantial decrement in quality of life. Time to diagnosis has not significantly shortened over the decade 2006–2015, but symptoms are less severe when diagnosis occurs. Harmonising clinical guidelines for intensified active case finding will help improve quality of life of people with coeliac disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lebwohl B, Ludvigsson JF, Green PH. Celiac disease and non-celiac gluten sensitivity. BMJ. 2015;351:h4347.CrossRef Lebwohl B, Ludvigsson JF, Green PH. Celiac disease and non-celiac gluten sensitivity. BMJ. 2015;351:h4347.CrossRef
2.
go back to reference Ludvigsson JF, Ciacci C, Green PH, Kaukinen K, Korponay-Szabo IR, Kurppa K, et al. Outcome measures in coeliac disease trials: the Tampere recommendations. Gut. 2018;67(8):1410–24.CrossRef Ludvigsson JF, Ciacci C, Green PH, Kaukinen K, Korponay-Szabo IR, Kurppa K, et al. Outcome measures in coeliac disease trials: the Tampere recommendations. Gut. 2018;67(8):1410–24.CrossRef
3.
go back to reference Cranney A, Zarkadas M, Graham ID, Butzner JD, Rashid M, Warren R, et al. The Canadian celiac health survey. Dig Dis Sci. 2007;52(4):1087–95.CrossRef Cranney A, Zarkadas M, Graham ID, Butzner JD, Rashid M, Warren R, et al. The Canadian celiac health survey. Dig Dis Sci. 2007;52(4):1087–95.CrossRef
4.
go back to reference Fuchs V, Kurppa K, Huhtala H, Collin P, Maki M, Kaukinen K. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol. 2014;49(11):1304–10.CrossRef Fuchs V, Kurppa K, Huhtala H, Collin P, Maki M, Kaukinen K. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol. 2014;49(11):1304–10.CrossRef
5.
go back to reference Fuchs V, Kurppa K, Huhtala H, Mäki M, Kekkonen L, Kaukinen K. Delayed celiac disease diagnosis predisposes to reduced quality of life and incremental use of health care services and medicines: a prospective nationwide study. United European Gastroenterol J. 2018;6(4):567–75.CrossRef Fuchs V, Kurppa K, Huhtala H, Mäki M, Kekkonen L, Kaukinen K. Delayed celiac disease diagnosis predisposes to reduced quality of life and incremental use of health care services and medicines: a prospective nationwide study. United European Gastroenterol J. 2018;6(4):567–75.CrossRef
6.
go back to reference Gray AM, Papanicolas IN. Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey. BMC Health Serv Res. 2010;10:105.CrossRef Gray AM, Papanicolas IN. Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey. BMC Health Serv Res. 2010;10:105.CrossRef
7.
go back to reference Green PHR, Stavropoulos SN, Panagi SG, Goldstein SL, McMahon DJ, Absan H, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 2001;96(1):126–31.CrossRef Green PHR, Stavropoulos SN, Panagi SG, Goldstein SL, McMahon DJ, Absan H, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 2001;96(1):126–31.CrossRef
8.
go back to reference Norstrom F, Lindholm L, Sandstrom O, Nordyke K, Ivarsson A. Delay to celiac disease diagnosis and its implications for health-related quality of life. BMC Gastroenterol. 2011;11:118.CrossRef Norstrom F, Lindholm L, Sandstrom O, Nordyke K, Ivarsson A. Delay to celiac disease diagnosis and its implications for health-related quality of life. BMC Gastroenterol. 2011;11:118.CrossRef
9.
go back to reference Vavricka SR, Vadasz N, Stotz M, Lehmann R, Studerus D, Greuter T, et al. Celiac disease diagnosis still significantly delayed – Doctor’s but not patients' delay responsive for the increased total delay in women. Dig Liver Dis. 2016;48(10):1148–54.CrossRef Vavricka SR, Vadasz N, Stotz M, Lehmann R, Studerus D, Greuter T, et al. Celiac disease diagnosis still significantly delayed – Doctor’s but not patients' delay responsive for the increased total delay in women. Dig Liver Dis. 2016;48(10):1148–54.CrossRef
10.
go back to reference Burden M, Mooney PD, Blanshard RJ, White WL, Cambray-Deakin DR, Sanders DS. Cost and availability of gluten-free food in the UK: in store and online. Postgrad Med J. 2015;91(1081):622–6.CrossRef Burden M, Mooney PD, Blanshard RJ, White WL, Cambray-Deakin DR, Sanders DS. Cost and availability of gluten-free food in the UK: in store and online. Postgrad Med J. 2015;91(1081):622–6.CrossRef
11.
go back to reference Lee AR, Ng DL, Zivin J, Green PH. Economic burden of a gluten-free diet. J Hum Nutr Diet. 2007;20(5):423–30.CrossRef Lee AR, Ng DL, Zivin J, Green PH. Economic burden of a gluten-free diet. J Hum Nutr Diet. 2007;20(5):423–30.CrossRef
12.
go back to reference Shah S, Akbari M, Vanga R, Kelly CP, Hansen J, Theethira T, et al. Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol. 2014;109(9):1304–11.CrossRef Shah S, Akbari M, Vanga R, Kelly CP, Hansen J, Theethira T, et al. Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol. 2014;109(9):1304–11.CrossRef
13.
go back to reference Singh J, Whelan K. Limited availability and higher cost of gluten-free foods. J Hum Nutr Diet. 2011;24(5):479–86.CrossRef Singh J, Whelan K. Limited availability and higher cost of gluten-free foods. J Hum Nutr Diet. 2011;24(5):479–86.CrossRef
14.
go back to reference Coeliac UK. National consultation to protect gluten free prescribing in England 2018. Coeliac UK. National consultation to protect gluten free prescribing in England 2018.
15.
go back to reference Black JL, Orfila C. Impact of coeliac disease on dietary habits and quality of life. J Hum Nutr Diet. 2011;24(6):582–7.CrossRef Black JL, Orfila C. Impact of coeliac disease on dietary habits and quality of life. J Hum Nutr Diet. 2011;24(6):582–7.CrossRef
16.
go back to reference Casellas F, Rodrigo L, Vivancos JL, Riestra S, Pantiga C, Baudet JS, et al. Factors that impact health-related quality of life in adults with celiac disease: a multicenter study. World J Gastroenterol. 2008;14(1):46–52.CrossRef Casellas F, Rodrigo L, Vivancos JL, Riestra S, Pantiga C, Baudet JS, et al. Factors that impact health-related quality of life in adults with celiac disease: a multicenter study. World J Gastroenterol. 2008;14(1):46–52.CrossRef
17.
go back to reference Lee AR, Ng DL, Diamond B, Ciaccio EJ, Green PH. Living with coeliac disease: survey results from the U.S.A. J Hum Nutr Diet. 2012;25(3):233–8.CrossRef Lee AR, Ng DL, Diamond B, Ciaccio EJ, Green PH. Living with coeliac disease: survey results from the U.S.A. J Hum Nutr Diet. 2012;25(3):233–8.CrossRef
18.
go back to reference Stasi E, Marafini I, Caruso R, Soderino F, Angelucci E, Del Vecchio Blanco G, et al. Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet. J Clin Gastroenterol. 2016;50(3):239–43.CrossRef Stasi E, Marafini I, Caruso R, Soderino F, Angelucci E, Del Vecchio Blanco G, et al. Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet. J Clin Gastroenterol. 2016;50(3):239–43.CrossRef
20.
go back to reference Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Econ. 1996;5(2):141–54.CrossRef Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Econ. 1996;5(2):141–54.CrossRef
22.
go back to reference Cameron AC, Trivedi PK. Microeconometrics using Stata. Texas: Stata Press; 2009. Cameron AC, Trivedi PK. Microeconometrics using Stata. Texas: Stata Press; 2009.
24.
go back to reference Nachman F, del Campo MP, Gonzalez A, Corzo L, Vazquez H, Sfoggia C, et al. Long-term deterioration of quality of life in adult patients with celiac disease is associated with treatment noncompliance. Dig Liver Dis. 2010;42(10):685–91.CrossRef Nachman F, del Campo MP, Gonzalez A, Corzo L, Vazquez H, Sfoggia C, et al. Long-term deterioration of quality of life in adult patients with celiac disease is associated with treatment noncompliance. Dig Liver Dis. 2010;42(10):685–91.CrossRef
25.
go back to reference West J, Fleming KM, Tata LJ, Card TR, Crooks CJ. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol. 2014;109(5):757–68.CrossRef West J, Fleming KM, Tata LJ, Card TR, Crooks CJ. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol. 2014;109(5):757–68.CrossRef
26.
go back to reference Paarlahti P, Kurppa K, Ukkola A, Collin P, Huhtala H, Maki M, et al. Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study. BMC Gastroenterol. 2013;13:75.CrossRef Paarlahti P, Kurppa K, Ukkola A, Collin P, Huhtala H, Maki M, et al. Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study. BMC Gastroenterol. 2013;13:75.CrossRef
27.
go back to reference Fernandez A, Gonzalez L, de-la-Fuente J. Coeliac disease: clinical features in adult populations. Rev Esp Enferm Dig. 2010;102(8):466–71.CrossRef Fernandez A, Gonzalez L, de-la-Fuente J. Coeliac disease: clinical features in adult populations. Rev Esp Enferm Dig. 2010;102(8):466–71.CrossRef
28.
go back to reference Logan RF, Tucker G, Rifkind EA, Heading RC, Ferguson A. Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. BMJ. 1983;286(6359):95.CrossRef Logan RF, Tucker G, Rifkind EA, Heading RC, Ferguson A. Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. BMJ. 1983;286(6359):95.CrossRef
29.
go back to reference Card TR, Siffledeen J, West J, Fleming KM. An excess of prior irritable bowel syndrome diagnoses or treatments in celiac disease: evidence of diagnostic delay. Scand J Gastroenterol. 2013;48(7):801–7.CrossRef Card TR, Siffledeen J, West J, Fleming KM. An excess of prior irritable bowel syndrome diagnoses or treatments in celiac disease: evidence of diagnostic delay. Scand J Gastroenterol. 2013;48(7):801–7.CrossRef
30.
go back to reference Castilhos AC, Gonçalves BC, Macedo E Silva M, Lanzoni LA, Metzger LR, Kotze LMS, et al. Quality of life evaluation in celiac patients from southern Brazil. Arq Gastroenterol. 2015;52:171–5.CrossRef Castilhos AC, Gonçalves BC, Macedo E Silva M, Lanzoni LA, Metzger LR, Kotze LMS, et al. Quality of life evaluation in celiac patients from southern Brazil. Arq Gastroenterol. 2015;52:171–5.CrossRef
31.
go back to reference Oza SS, Akbari M, Kelly CP, Hansen J, Theethira T, Tariq S, et al. Socioeconomic risk factors for celiac disease Burden and symptoms. J Clin Gastroenterol. 2016;50(4):307–12.CrossRef Oza SS, Akbari M, Kelly CP, Hansen J, Theethira T, Tariq S, et al. Socioeconomic risk factors for celiac disease Burden and symptoms. J Clin Gastroenterol. 2016;50(4):307–12.CrossRef
32.
go back to reference Villafuerte-Galvez J, Vanga RR, Dennis M, Hansen J, Leffler DA, Kelly CP, et al. Factors governing long-term adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther. 2015;42(6):753–60.CrossRef Villafuerte-Galvez J, Vanga RR, Dennis M, Hansen J, Leffler DA, Kelly CP, et al. Factors governing long-term adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther. 2015;42(6):753–60.CrossRef
33.
go back to reference Halmos EP, Deng M, Knowles SR, Sainsbury K, Mullan B, Tye-Din JA. Food knowledge and psychological state predict adherence to a gluten-free diet in a survey of 5310 Australians and New Zealanders with coeliac disease. Aliment Pharmacol Ther. 2018;48(1):78–86.CrossRef Halmos EP, Deng M, Knowles SR, Sainsbury K, Mullan B, Tye-Din JA. Food knowledge and psychological state predict adherence to a gluten-free diet in a survey of 5310 Australians and New Zealanders with coeliac disease. Aliment Pharmacol Ther. 2018;48(1):78–86.CrossRef
34.
go back to reference Bandini J. ‘Is it just food?’: The social implications of celiac disease as a disability. Disabil Soc. 2015;30(10):1577–81.CrossRef Bandini J. ‘Is it just food?’: The social implications of celiac disease as a disability. Disabil Soc. 2015;30(10):1577–81.CrossRef
35.
go back to reference Lee A, Newman JM. Celiac diet: its impact on quality of life. J Am Diet Assoc. 2003;103(11):1533–5.CrossRef Lee A, Newman JM. Celiac diet: its impact on quality of life. J Am Diet Assoc. 2003;103(11):1533–5.CrossRef
37.
go back to reference Nachman F, Maurino E, Vazquez H, Sfoggia C, Gonzalez A, Gonzalez V, et al. Quality of life in celiac disease patients: prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment. Dig Liver Dis. 2009;41(1):15–25.CrossRef Nachman F, Maurino E, Vazquez H, Sfoggia C, Gonzalez A, Gonzalez V, et al. Quality of life in celiac disease patients: prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment. Dig Liver Dis. 2009;41(1):15–25.CrossRef
39.
go back to reference Hershcovici T, Leshno M, Goldin E, Shamir R, Israeli E. Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. Aliment Pharmacol Ther. 2010;31(8):901–10.PubMed Hershcovici T, Leshno M, Goldin E, Shamir R, Israeli E. Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. Aliment Pharmacol Ther. 2010;31(8):901–10.PubMed
40.
go back to reference Ludvigsson JF, Card TR, Kaukinen K, Bai J, Zingone F, Sanders DS, et al. Screening for celiac disease in the general population and in high-risk groups. United European Gastroenterol J. 2015;3(2):106–20.CrossRef Ludvigsson JF, Card TR, Kaukinen K, Bai J, Zingone F, Sanders DS, et al. Screening for celiac disease in the general population and in high-risk groups. United European Gastroenterol J. 2015;3(2):106–20.CrossRef
41.
go back to reference Park KT, Tsai R, Wang L, Khavari N, Bachrach L, Bass D. Cost-effectiveness of universal serologic screening to prevent nontraumatic hip and vertebral fractures in patients with celiac disease. Clin Gastroenterol Hepatol. 2013;11(6):645–53.CrossRef Park KT, Tsai R, Wang L, Khavari N, Bachrach L, Bass D. Cost-effectiveness of universal serologic screening to prevent nontraumatic hip and vertebral fractures in patients with celiac disease. Clin Gastroenterol Hepatol. 2013;11(6):645–53.CrossRef
42.
go back to reference Shamir R, Hernell O, Leshno M. Cost-effectiveness analysis of screening for celiac disease in the adult population. Med Decis Mak. 2006;26(3):282–93.CrossRef Shamir R, Hernell O, Leshno M. Cost-effectiveness analysis of screening for celiac disease in the adult population. Med Decis Mak. 2006;26(3):282–93.CrossRef
43.
go back to reference Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63(8):1210–28.CrossRef Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63(8):1210–28.CrossRef
44.
go back to reference Murch S, Jenkins H, Auth M, Bremner R, Butt A, France S, et al. Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of coeliac disease in children. Arch Dis Child. 2013;98(10):806–11.CrossRef Murch S, Jenkins H, Auth M, Bremner R, Butt A, France S, et al. Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of coeliac disease in children. Arch Dis Child. 2013;98(10):806–11.CrossRef
Metadata
Title
The impact of diagnosis on health-related quality of life in people with coeliac disease: a UK population-based longitudinal perspective
Authors
Mara Violato
Alastair Gray
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2019
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-019-0980-6

Other articles of this Issue 1/2019

BMC Gastroenterology 1/2019 Go to the issue